GlassScriptPhysician profile
Janna C Lambert
NPI 1174754824
$825.17
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $318 · 2023: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.34 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $99.70 | 2022-2023 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.80 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $54.23 | 2021 | |
| Avanir Pharmaceuticals, INC. | $41.33 | 2021-2022 | |
| Lilly USA, LLC | $37.31 | 2021 | |
| Lundbeck LLC | $37.19 | 2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $29.01 | 2022 | |
| Alkermes, INC. | $25.73 | 2021 | |
| Acadia Pharmaceuticals INC | $17.71 | 2021 | |
| Smith+Nephew, INC. | $16.71 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.98 | 2022 | |
| Novo Nordisk INC | $13.34 | 2021 | |
| Axsome Therapeutics, INC. | $13.12 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.99 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janna Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.